| Literature DB >> 26380226 |
Luiz E Bermudez1, Lia Danelishvili2, Lmar Babrack3, Tuan Pham2.
Abstract
Mycobacterium avium subsp. hominissuis (MAH) is an environmental bacteria that infects immunocompromised humans. MAH cases are increasing in incidence, making it crucial to gain knowledge of the pathogenic mechanisms associated with the bacterium. MAH infects macrophages and after several days the infection triggers the phagocyte apoptosis. Many of the intracellular MAH escape the cell undergoing apoptosis leading to infection of neighboring macrophages. We screened a transposon bank of MAH mutants in U937 mononuclear phagocytes for the inability to escape macrophages undergoing apoptosis. Mutations in genes; MAV_2235, MAV_2120, MAV_2410, and MAV_4563 resulted in the inability of the bacteria to exit macrophages upon apoptosis. Complementation of the mutations corrected the phenotype either completely or partially. Testing for the ability of the mutants to survive in macrophages compared to the wild-type bacterium revealed that the mutant clones were not attenuated up to 4 days of infection. Testing in vivo, however, demonstrated that all the MAH clones were attenuated compared with the wild-type MAC 104 in tissues of mice. Although the mechanism associated with the bacterial inability to leave apoptotic macrophages is unknown, the identification of macrophage cytoplasm targets for the MAH proteins suggest that they interfere either with protein degradation machinery or post-translation mechanisms. The identification of tatC as a MAH protein involved in the ability of MAH to leave macrophages, suggests that secreted effector(s) are involved in the process. The study reveals a pathway of escape from macrophages, not shared with Mycobacterium tuberculosis.Entities:
Keywords: M. avium; MAV_2122; MAV_2235; MAV_4564; TaTC; apoptosis; exit from macrophages; macrophages
Mesh:
Substances:
Year: 2015 PMID: 26380226 PMCID: PMC4548235 DOI: 10.3389/fcimb.2015.00063
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Genome organization of the four genes identified to be associated with the ability to escape macrophages. MAV_2235 encodes for an adenylate cyclase, MAV_2120 encodes for a divalent cation transport, MAV_4563 encodes for a protein of unknown function, and MAV_2410 encodes for the transport protein tatC.
Ability of MAH to escape U937 macrophages.
| MAC 104 WT | Undetectable | 135 ± 26 | 3.2 ±0.3 × 103 |
| MAV_2235 | Undetectable | Undetectable | Undetectable |
| MAV_2235c | Undetectable | 96 ± 41 | 1.9 ±0.6 × 103 |
| MAV_2120 | Undetectable | Undetectable | Undetectable |
| MAV_2120c | Undetectable | Undetectable | 8.9 ±0.5 × 102 |
| MAV_2410 | Undetectable | Undetectable | Undetectable |
| MAV_2410c | Undetectable | 129 ± 38 | 5.1 ±0.2 × 103 |
| MAV_4563 | Undetectable | Undetectable | Undetectable |
| MAV_4563c | Undetectable | 102 ± 61 | 3.1 ±0.4 × 103 |
U937 macrophages were infected with the WT 104 or with mutants. The four mutants identified initially were further evaluated for the ability to escape THP-1 macrophages and human monocyte derived macrophages. Viable bacteria in the supernatant were quantified by plating on 7H10 agar plates. We also examined this characteristic using the complement genes (functional), MAV_2235c, MAV_2120c, MAV_2410c, and MAV_4563c. The results obtained were similar to the results using U937 phagocytes.
(A,B) Ability of the identified mutants to survive in THP-1 and human monocyte-derived macrophages in culture.
| MAC 104 WT | 3.2 ±0.4 × 105 | 4.0 ±0.3 × 106 | 6.3 ±0.2 × 106 | 5.1 ±0.4 × 104 |
| MAV_2235 mutant | 3.9 ±0.4 × 105 | 3.6 ±0.5 × 106 | 3.9 ±0.4 × 106 | Undetectable |
| MAV_2120 mutant | 3.5 ±0.5 × 105 | 3.7 ±0.3 × 106 | 4.1 ±0.3 × 106 | Undetectable |
| MAV_2410 mutant | 3.3 ±0.3 × 105 | 1.7 ±0.4 × 105( | 8.2 ±0.4 × 104 | 7.3 ±0.4 × 105 |
| MAV_4563 mutant | 4.1 ±0.4 × 106 | 4.2 ±0.5 × 106 | 6.0 ±0.4 × 105 | undetectable |
| MAC 104 WT | 5.1 ±0.3 × 105 | 6.3 ±0.4 × 106 | 8.0 ±0.4 × 106 | 7.3 ±0.4 × 104 |
| MAV_2235 mutant | 4.3 ±0.4 × 105 | 4.2 ±0.3 × 106 | 4.7 ±0.2 × 106 | Undetectable |
| MAV_2120 mutant | 5.8 ±0.6 × 105 | 5.9 ±0.4 × 106 | 6.2 ±0.4 × 106 | Undetectable |
| MAV_2410 mutant | 3.8 ±0.3 × 105 | 5.9 ±0.3 × 105( | 8.4 ±0.3 × 104 | 1.6 ±0.5 × 105 |
| MAV_4563 mutant | 5.6 ±0.5 × 106 | 4.9 ±0.3 × 106 | 6.6 ±0.4 × 106 | undetectable |
p < 0.05 compared with WT MAC 104 bacterium.
Number of bacteria/ml of the macrophage lysate.
Figure 2C57/BL6 black mice were infected with MAH (WT and mutants) and the course of bacterial infection was monitored for 3 weeks. *p < 0.05 compared with the number of bacteria in mice infected with the WT MAC104.
Macrophage targets by identified using the two-hybrid system for the interactions of MAV_2120, MAV_2235, and MAV_4563 encoded proteins.
| MAV_2210 | COP9 signalosome subunit 5 (COPS5) |
| (Mn++/Fe++ transporter) | |
| MAV_2235 | PNN- serine/arginine-rich protein |
| Adenylate Cyclase | |
| MAV_4563 | Ubiquitin specific peptidase 48 |
| Hypothetical protein |
Figure 3(A) The yeast two-hybrid interaction of MAV_2120, MAV_2235, and MAV_4563 proteins with the host target proteins. (a) COP9 signalosome subunit 5 (CSN5), (b) eukaryotic translation termination factor 1 (ETF1), (c) PNN-interacting serine/arginine-rich protein (PNISR), (d) serine/arginine-rich splicing factor 5 (SRSF5), (e) SECIS binding protein 2-like (SECISBP2L), (f) ubiquitin specific peptidase 48 (USP48). (B) Co-immunoprecipitation of MAV_2120 and MAV_4563 from M. smegmatis cell lysates using recombinant 6xHN:CSN5 and 6xHN:USP48 proteins. Bound proteins were captured on His-columns and visualized by western blotting using 6xHN and Flag antibodies.